Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies

Paolo Verdecchia, Gilles Dagenais, Jeff Healey, Peggy Gao, Antonio L. Dans, Irina Chazova, Azan S. Binbrek, Gianluca Iacobellis, Rafael Ferreira, Nicolaas Holwerda, Nicholas Karatzas, Matyas Keltai, Giuseppe Mancia, Peter Sleight, Koon Teo, Salim Yusuf

Research output: Contribution to journalArticle

44 Scopus citations

Fingerprint Dive into the research topics of 'Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies'. Together they form a unique fingerprint.

Medicine & Life Sciences